| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.71B | +13.3% |
| Gross Profit | $642.1M | +16.5% |
| R&D Expense | $29.7M | +30.3% |
| Operating Income | $317.4M | +11.7% |
| Pre-tax Income | $138.0M | +11.8% |
| Income Tax | $36.3M | +44.4% |
| Net Income | $101.8M | +3.5% |
| EPS (Basic) | $0.57 | -1.7% |
| EPS (Diluted) | $0.56 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $123.1M | -20.4% |
| Inventory | $146.9M | +9.2% |
| Current Assets | $675.9M | +1.2% |
| Total Assets | $2.89B | +1.9% |
| Current Liabilities | $484.3M | +1.2% |
| Total Liabilities | $2.49B | -19.8% |
| Stockholders' Equity | $392.1M | +241.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $211.7M | +45.5% |
| Capital Expenditures | $53.7M | +23.4% |
| Investing Cash Flow | -$91.6M | -4.4% |
| Financing Cash Flow | -$157.9M | -109.5% |
| Free Cash Flow | $158.0M | +55.0% |